Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Diclofenac Epolamine Patch for Pain Caused by Local Soft Tissue Injury
CTR20232884Phase 3Completed
- Sponsor
- Nanjing Haina Pharmaceutical Technology
- Start
- Sep 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of diclofenac in soft tissue injury (3 arms), sponsored by Nanjing Haina Pharmaceutical Technology. Started Sep 2023; status: completed.
02
Drugs
diclofenac
03
Conditions
soft tissue injury
Beyond the preview
Go deeper on CTR20232884.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20232884.